ImQuest BioSciences Taps Warschawski to Create New Website and Collateral Materials

BALTIMORE – September 24, 2013 – Warschawski, a full service branding, marketing, public relations, advertising and interactive agency, announced today that ImQuest BioSciences, Inc., has hired Warschawski to create a new website and collateral materials for the company. Warschawski recently worked with ImQuest BioSciences, a provider of pre-clinical research and drug development services, to clarify its brand DNA and brand strategy. Based on the success of this collaboration, Warschawski has been retained to create new marketing materials that represent the new ImQuest BioSciences brand.

ImQuest BioSciences will work with Warschawski’s web experts to redesign and refresh their current website to clearly reflect the company’s brand. The redesign will optimize the site for search purposes as well as to create an improved user experience. Warschawski will develop a user-friendly content management system that will allow the team at ImQuest ease-of-use when administering website updates. Additionally, Warschawski will create new marketing collateral materials that reinforce the company’s brand.

“ImQuest BioSciences is a leading provider of research and development for infectious disease and cancer therapeutic and prevention products,” said David Warschawski, CEO of Warschawski. “We are excited to work with the ImQuest team to redesign their website and collateral materials to reinforce the company’s powerful brand values. It’s exciting to work with such a revolutionary company that discovers and develops products which improve the lives of people throughout the world.”

“ImQuest is very pleased to continue our marketing and public relations campaign with Warschawski,” said Dr. Robert W. Buckheit, Jr., President and Chief Scientific Officer of ImQuest. “We look forward to our continuing efforts to more effectively and creatively inform the scientific community of our unique and customized approach to the successful development of new and novel anti-infective and anti-cancer drugs, as well as our evolving focus on emerging diseases and women’s health. We believe this relationship to be a major step in the growth of the ImQuest brand.”

Warschawski is dedicated to providing clients with the highest quality of branding, marketing, PR, advertising, interactive and creative design services. Warschawski has won the top recognition of being named “U.S. Small Agency of the Year” for four of the past six years. For ten consecutive years, it also has been ranked as one of the top 30 “Best Agencies to Work For” in the U.S. In 2010, Warschawski was named “U.S. Small Agency of the Year” and the “Best Small Agency to Work For” in the U.S. The company, whose clients include Fortune 500 and Inc. 500 companies, has won more than 200 awards for its marketing communications work over the last 15 years. Warschawski was founded in 1996 and is headquartered in Baltimore, MD.

ImQuest BioSciences, based in Frederick, Maryland, is a contract research organization (CRO) focused on the development of agents for the prevention and treatment of infectious disease, cancer, and inflammatory disease, as well as specialized capabilities to support the preformulation and formulation development for optimal product delivery. The company’s proprietary ImQuestSUCCESS platform has assisted their clients in expediting the development of products for clinical evaluation through rapid identification of candidates with a high probability of clinical success by reducing the risk associated with failure experienced during clinical development. ImQuest was named Small Business of the Year by the Tech Council of Maryland (2011) and Best Places to Work (2012) by Frederick County, Maryland. Robert W. Buckheit, Jr., Ph.D., Founder and President, was Frederick’s Entrepreneur of the Year in 2011.